Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies

1 Feb 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Viral Infectious Diseases and Gene Expression in Insects
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25721207
DOI: 10.1038/cgt.2014.81

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesPMID 25721207Read ↗

Current Non-Viral-Based Strategies to Manufacture CAR-T CellsSemantic proximity Read ↗

Revolutionizing CAR T Cell Therapies: Innovations in Genetic Engineering and Manufacturing to Enhance Efficacy and AccessibilitySemantic proximity Read ↗

Production of CAR T-cells by GMP-grade lentiviral vectors: latest advances and future prospectsSemantic proximity Read ↗

New Cell Sources for T Cell Engineering and Adoptive ImmunotherapySemantic proximity Read ↗

Targeted gene delivery systems for T-cell engineeringSemantic proximity Read ↗

CAR T Cell Therapy: A Versatile Living DrugSemantic proximity Read ↗

Engineered T cells for anti-cancer therapySemantic proximity Read ↗

Lentivirus for CAR-T and Other Cell Therapy Products: A Microbiological and Biosafety PerspectiveSemantic proximity Read ↗

Manufacturing genetically modified T cells for clinical trialsSemantic proximity Read ↗

Strategies to genetically engineer T cells for cancer immunotherapySemantic proximity Read ↗

Cell-derived Nanoparticles Provide a Robust Platform to Manufacture Therapeutic T cells.Semantic proximity Read ↗

Toward precision manufacturing of immunogene T-cell therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.